Chan-Ho Kim - Search Results

Year	Number of Results
2009	2
2011	2
2012	4
2013	12
2014	12
2015	5
2016	1
2017	2
2018	1
2019	2
2020	3
2021	7
2022	13
2023	7
2024	3

1

Curvature-sensing peptide inhibits tumour-derived exosomes for enhanced cancer immunotherapy.

Shin S, Ko H, Kim CH, Yoon BK, Son S, Lee JA, Shin JM, Lee J, Song SH, Jackman JA, Park JH. Shin S, et al. Among authors: kim ch. Nat Mater. 2023 May;22(5):656-665. doi: 10.1038/s41563-023-01515-2. Epub 2023 Mar 23. Nat Mater. 2023. PMID: 36959501

2

Functional Extracellular Vesicles for Regenerative Medicine.

Kim HY, Kwon S, Um W, Shin S, Kim CH, Park JH, Kim BS. Kim HY, et al. Among authors: kim ch. Small. 2022 Sep;18(36):e2106569. doi: 10.1002/smll.202106569. Epub 2022 Mar 23. Small. 2022. PMID: 35322545 Review.

3

Recent advances in nanomaterial-based augmented sonodynamic therapy of cancer.

Um W, E K PK, Lee J, Kim CH, You DG, Park JH. Um W, et al. Among authors: kim ch. Chem Commun (Camb). 2021 Mar 18;57(23):2854-2866. doi: 10.1039/d0cc07750j. Chem Commun (Camb). 2021. PMID: 33625416 Review.

4

Disease-microenvironment modulation by bare- or engineered-exosome for rheumatoid arthritis treatment.

Lee ES, Ko H, Kim CH, Kim HC, Choi SK, Jeong SW, Lee SG, Lee SJ, Na HK, Park JH, Shin JM. Lee ES, et al. Among authors: kim ch. Biomater Res. 2023 Aug 28;27(1):81. doi: 10.1186/s40824-023-00418-2. Biomater Res. 2023. PMID: 37635253 Free PMC article. Review.

5

Soluble receptors for advanced glycation end-products prevent unilateral ureteral obstruction-induced renal fibrosis.

Kim CH, Kang HY, Kim G, Park J, Nam BY, Park JT, Han SH, Kang SW, Yoo TH. Kim CH, et al. Front Pharmacol. 2023 May 16;14:1172269. doi: 10.3389/fphar.2023.1172269. eCollection 2023. Front Pharmacol. 2023. PMID: 37261287 Free PMC article.

6

The role of the gut microbiota in acute kidney injury: a new therapeutic candidate?

Kim CH, Moon SJ. Kim CH, et al. Kidney Res Clin Pract. 2021 Dec;40(4):505-507. doi: 10.23876/j.krcp.21.241. Epub 2021 Nov 29. Kidney Res Clin Pract. 2021. PMID: 34922426 Free PMC article. No abstract available.

7

Self-immolative nanosensitizer for glutathione depletion- assisted sonodynamic therapy.

Kim CH, You DG, E K PK, Han KH, Um W, Lee J, Lee JA, Jung JM, Kang H, Park JH. Kim CH, et al. Theranostics. 2022 Oct 24;12(17):7465-7475. doi: 10.7150/thno.75007. eCollection 2022. Theranostics. 2022. PMID: 36438485 Free PMC article.

8

Cavitation-Inducible Mesoporous Silica-Titania Nanoparticles for Cancer Sonotheranostics.

Lee J, Kim JH, You DG, Kim S, Um W, Jeon J, Kim CH, Joo H, Yi GR, Park JH. Lee J, et al. Among authors: kim ch. Adv Healthc Mater. 2020 Oct;9(19):e2000877. doi: 10.1002/adhm.202000877. Epub 2020 Sep 7. Adv Healthc Mater. 2020. PMID: 32893995

9

Recruitment of dendritic cells using 'find-me' signaling microparticles for personalized cancer immunotherapy.

Lee JA, Shin JM, Song SH, Kim CH, Son S, Shin S, Park JH. Lee JA, et al. Among authors: kim ch. Biomaterials. 2022 Mar;282:121412. doi: 10.1016/j.biomaterials.2022.121412. Epub 2022 Feb 15. Biomaterials. 2022. PMID: 35184011

10

Functionally Masked Antibody to Uncouple Immune-Related Toxicities in Checkpoint Blockade Cancer Therapy.

Song SH, Ghosh T, You DG, Joo H, Lee J, Lee J, Kim CH, Jeon J, Shin S, Park JH. Song SH, et al. Among authors: kim ch. ACS Nano. 2023 Jun 13;17(11):10065-10077. doi: 10.1021/acsnano.2c12532. Epub 2023 May 15. ACS Nano. 2023. PMID: 37184643

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

70 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

70 results

Results by year